Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11526 posts found.

teva_copy

EU grants marketing authorisation for Teva’s asthma drug Cinqaero

August 19, 2016 Medical Communications, Sales and Marketing EU, Teva, approval, asthma, cinqaero, eosinophilic

The European Commission has granted marketing authorisation for Teva’s Cinqaero (reslizumab), as an odd-on therapy in adult patients with severe …
News

Bayer’s liver cancer drug not cost-effective, says NICE

August 19, 2016 Medical Communications, Sales and Marketing Bayer, CDF, NICE, Nexavar, lung cancer

NICE has deemed Bayer’s liver cancer drug Nexavar (sorafenib) as not cost-effective. The drug is currently available on the Cancer …
News
gavel

Former shareholders sue Valeant, alleging “vast fraud”

August 19, 2016 Medical Communications, Sales and Marketing Valeant, fraud, lawsuit, t rowe price

Valeant Pharmaceuticals has confirmed that it is being sued by one its former largest shareholders, T Rowe Price, who claim …
News
shutterstock_512649

Chinese investors plan $1 billion US biotech site

August 18, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

China’s state-backed developer Greenland Holdings is set to jointly invested over $1 billion in a San Francisco-based biotech industrial park …
News
remicade_packshot

J&J loses Remicade patent fight, pledges to continue fight against biosimilars

August 18, 2016 Research and Development, Sales and Marketing Johnson and Johnson, Remicade, biosimilar, biosimilars, infliximab, patent

Johnson and Johnson has announced that it has lost in a patent dispute between biosimilar makers Celltrion and Hospira, relating …
News

Pfizer’s Xalkori price drop secures NICE recommendation

August 18, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NICE, Pfizer, Xalkori, crizotinib, lung cancer

The National Institute for Health and Care Excellence (NICE) has recommended Pfizer’s Xalkori (crizotinib) as a treatment for lung cancer, …
News
merck_incweb

MSD joins Medivation race, says reports

August 18, 2016 Manufacturing and Production, Research and Development, Sales and Marketing MSD, Medivation, Merck, Pfizer, Sanofi, Xtandi, takeover

MSD, known as Merck in the US and Canada, is said to have declared its interest in buying US oncology …
News

NICE says Afinitor and Imbruvica “may be removed” from Cancer Drugs Fund

August 18, 2016 Research and Development, Sales and Marketing Afinitor, Cancer Drugs Fund, Janssen, NICE, Novartis, imbruvica

NICE has published draft guidance advising the removal of Novartis’s Afinitor (everolimus) and Janssen’s Imbruvica (ibrutinib) from the Cancer Drugs …
News
praluent_75mg_pen_box_hr

Amgen, Sanofi cholesterol medicines “not cost-effective”, need to drop price by two-thirds

August 17, 2016 Research and Development, Sales and Marketing Amgen, QALY, Regeneron, Repatha, Sanofi, cost effective, cost-effective, praluent

A new study published in JAMA has suggested that Amgen, Sanofi and Regeneron would have to reduce their prices for …
News

Ashfield launches Global Impact On Society Initiative

August 16, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Ashfield, part of UDG Healthcare plc (LON: UDG), a global leader in providing outsourced healthcare services to pharmaceutical, device and …
News
Press release
ucb_logo_pole2

US court rules in favour of UCB in patent dispute, shares jump

August 16, 2016 Manufacturing and Production, Research and Development, Sales and Marketing UCB, lacosamide, patent, vimpat

UCB has received a major boost after a Delaware district court confirmed the validity of the company’s patents on one …
News
top_ten

Top ten stories in the pharmaceutical industry this week

August 15, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biggest stories, pharma, pharmafile, stories of the week, top 10

It’s Monday and we’re just getting back to it after a busy week in pharma. Unfortunately, it was mostly bad …
News
shutterstock_76507048

Acute coronary syndrome market to grow to over $12 billion by 2022

August 15, 2016 Research and Development, Sales and Marketing GlobalData, acute coronary syndrome

The acute coronary syndrome (ACS) market is forecast to rise from $7.8 billion in 2015 to $12.1 billion by 2022 …
News
doc_writing

Endo to withdraw FDA application for abuse-deterrent labelling on opioid drug

August 15, 2016 Sales and Marketing Endo, Endo International, abuse deterrent, opioid

Endo International has announced that, following discussions with the US Food and Drug Administration (FDA), it has decided to withdraw …
News
novartis_side_building

Novartis invests €100 million to expand French manufacturing plant

August 15, 2016 Manufacturing and Production, Sales and Marketing Novartis, manufacturing

Novartis has sealed the deal with construction firm Jacobs Engineering group to expand production operations at its France Center of …
News
The Gateway to Local Adoption Series

Latest content

Closing the immunisation gap: partnership working that delivered at scale

June 5, 2026

Phase 2 study explores imaging approach for interstitial lung disease

June 5, 2026

Laverock secures funding for gene-control platform development

June 4, 2026

LifeArc and Elpida partner to advance gene therapies for ultra-rare childhood diseases

June 3, 2026

Well Pharmacy and Alzheimer’s Society launch dementia partnership

June 2, 2026